文献速递间质性肺疾病

病理确诊纤维化型非特异性间质性肺炎的预后因素与疾病行为

Prognostic factors and disease behaviour of pathologically proven fibrotic non-specific interstitial pneumonia.
PubMed 文献 · Respirology · 2018-04-24

本研究回顾157例经外科肺活检确诊的纤维化型非特异性间质性肺炎(f-NSIP)患者,按肺功能长期变化分为进展型与稳定型。多因素分析显示特发性(非IPAF)f-NSIP和进展型疾病为死亡负性预后因素,1年治疗反应差是进展型疾病的独立预测因素但与生存无关。IPAF诊断有助于识别特发性f-NSIP中的良好预后,但部分患者即使治疗仍呈进展。

要点

  • 特发性(非IPAF)f-NSIP和进展型疾病是死亡的负性预后因素。
  • 1年治疗反应差是进展型疾病的独立预测因素,但与生存无关。
  • IPAF诊断有助于识别特发性f-NSIP中的良好预后。

核心结论

  • IPAF诊断有助于识别特发性f-NSIP中的良好预后,但部分特发性f-NSIP患者无论是否IPAF,尽管接受治疗仍呈进展性疾病。
  • 进展型疾病的定义可能有助于f-NSIP治疗决策的临床制定。

研究设计与样本

  • 回顾性分析157例经外科肺活检确诊的f-NSIP连续患者病历。
  • 根据肺功能长期变化将疾病行为分为进展型(FVC斜率相对年下降≥5%和/或DLCO%斜率相对年下降≥7.5%)或稳定型。
  • 采用logistic回归和Cox回归模型确定疾病行为和预后的预测因素。

主要发现

  • f-NSIP队列包括具有自身免疫特征的间质性肺炎(IPAF)36.9%、特发性(非IPAF)22.3%和结缔组织病相关间质性肺病40.8%。
  • 多因素分析显示特发性(非IPAF)f-NSIP和进展型疾病为死亡的负性预后因素。
  • 1年治疗反应差是进展型疾病的独立预测因素,但与生存无关。
  • 基于肺功能变化的疾病行为方面,部分IPAF f-NSIP患者呈进展性病程。

关键数值与推荐

  • 进展型疾病定义:FVC斜率相对年下降≥5%和/或DLCO%斜率相对年下降≥7.5%。

临床怎么用

  • 对f-NSIP患者应评估IPAF诊断以帮助判断预后。
  • 基于肺功能长期变化定义进展型疾病可能有助于临床治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Non-specific interstitial pneumonia (NSIP) has heterogeneous characteristics in terms of background, disease behaviour and prognosis. This study of fibrotic NSIP (f-NSIP) aimed to elucidate prognosis and disease behaviour from the viewpoint of clinical background and determine whether long-term change of pulmonary function could provide useful prognostic information. METHODS: We analysed the medical records of 157 consecutive patients diagnosed with f-NSIP by surgical lung biopsy. Disease behaviour was categorized into two groups depending on long-term change of pulmonary function: progressive type (relative ≥5%/year decline in the slope of forced vital capacity and/or relative ≥7.5%/year decline in the slope of %diffusing capacity of lung carbon monoxide) or stable type. Predictors of disease behaviour and prognosis were determined using logistic and Cox regression models. RESULTS: Our f-NSIP cohort included interstitial pneumonia with autoimmune features (IPAF) (36.9%), idiopathic (non-IPAF) (22.3%) and connective tissue disease-associated interstitial lung disease (40.8%). Multivariate analysis showed that idiopathic (non-IPAF) f-NSIP and progressive type disease were negative prognostic factors of mortality. Poor treatment response at 1 year was an independent predictor of progressive type disease, but was not related to survival. In terms of disease behaviour based on pulmonary function change, some patients with IPAF f-NSIP showed a progressive course. CONCLUSION: Although an IPAF diagnosis was useful for identifying good prognosis in idiopathic f-NSIP, some idiopathic f-NSIP patients with or without IPAF showed progressive disease despite therapy. The definition of progressive type disease may be useful in clinical decision-making when determining therapy for f-NSIP.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Yamakawa H, Kitamura H, Takemura T, et al. Prognostic factors and disease behaviour of pathologically proven fibrotic non-specific interstitial pneumonia. Respirology. 2018. PMID: 29693298. doi:10.1111/resp.13313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。